Skip to main content

Table 5 Remission Status by gender, age and history of anxiety and logistic regression analysis to determine the relationship with probability of remission, completers (n = 42)

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

  Total in remission (MADRS ≤8) Total not in remission (MADRS >8) Odds ratio (95% CI) P-value
N (% of 42) 21 (50) 21 (50)   
Gender     
   Female, n (% of n = 39) 20 (51.3) 19 (48.7)   
   Male, n (% of n = 3) 1 (33.3) 2 (66.7) 3.33 (0.24-45.76) 0.350
History of anxiety     
   No, n (% of n = 13) 9 (69.2) 4 (30.8)   
   Yes, n (% of n = 29) 12 (41.4) 17 (58.6) 4.10 (0.89-18.89) 0.095
Age group     
   Aged <45, n (% of n = 22) 9 (40.9) 13 (59.1)   
   Aged ≥45, n (% of n = 20) 12 (60.0) 8 (40.0) 0.44 (0.12-1.63) 0.189
  1. Odds ratios for female vs. male, aged <45 vs. ≥45, no history of anxiety vs. no history of anxiety from logistic regression analysis